VidaVinci, Inc is a venture-backed, privately held biotech company on a mission to pioneer "a new modality to end all modalities". Our goal is to revolutionize drug discovery at scale, address the toughest challenges of existing modalities, and unlock high-impact therapies for patients.
Backed by top tier investors, the Company is co-founded by Drs. Gregory Verdine and Hal Barron--renowned industry leaders known for taking on the most daring scientific challenges. Built on a bold vision to redefine therapeutic innovation, we are pushing the boundaries of what’s possible in medicine.
Join us to shape the future of drug discovery.
Company Details
- Employees
- 22
- Founded
- 2024
- Address
- The Toughest Challenges Of Existing Modalities
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.vidavinci.com
Vidavinci, Inc. Questions
Vidavinci, Inc.'s website is http://www.vidavinci.com
Vidavinci, Inc.'s LinkedIn profile is https://www.linkedin.com/company/vidavinci-inc
Vidavinci, Inc. has
22 employees.
View email and phone details for 22
employees at Vidavinci, Inc..
Vidavinci, Inc.'s industry is
Biotechnology Research
Vidavinci, Inc.'s top competitors are
Rome Therapeutics,
Kymera Therapeutics,
Edelris,
Monte Rosa Therapeutics,
Vertex Pharmaceuticals,
Oddity Labs,
Relay Therapeutics,
Lifemine Therapeutics,
City Therapeutics,
Kestrel Therapeutics.
Vidavinci, Inc.'s categories are Biotechnology Research
Vidavinci, Inc.'s founding year is 2024
